Apollo | Sponsored by Alynlam Pharmaceuticals, Inc.

Apollo Clinical Trial

Apollo clinical trial
For myself.
For my family.
For the 10,000 of us with
TTR AMYLOIDOSIS (FAP).

Join Alnylam in our effort to advance a
potential new treatment option for
TTR amyloidosis (FAP).

Apollo clinical trial
For myself.
For my family.
For the 10,000 of us with
TTR AMYLOIDOSIS (FAP).

APOLLO is a global clinical trial
evaluating an investigational drug
for TTR amyloidosis with familial
amyloidotic polyneuropathy (FAP).